Management and Outcomes of ANCA-Associated Vasculitis at a Tertiary Healthcare Facility

Table 1

Baseline demographics and laboratory values at presentation.

Summary following inclusion and exclusion criteria	N  = 36
Age (years)^a	63.5 (54.5–71.5)
Gender (male, %)	23 (66.7)
Hypertension (%)	26 (72)
Hyperlipidaemia (%)	8 (22.2)
Ischaemic heart disease (%)	4 (11.1)
Gout (%)	3 (8.3)
Diabetes mellitus (%)	2 (5.6)
BVAS^b	15 ± 4
Creatinine^a (ml/min/1.73 m^2)	301.5 (169–718.5)
Anti-PR3/antiMPO titre^a (IU/ml)	28 (12.5–87.5)
Anti-MPO antibody positive (%)	20 (55.6)
Anti-PR3 antibody positive (%)	16 (44.4)

^aMedian (interquartile range). ^bMean ± standard deviation.